Oral administration of recombinant adeno-associated virus-mediated bone morphogenetic protein-7 suppresses CCl 4 -induced hepatic fibrosis in mice

Molecular Therapy

Volumn 20, Issue 11, 2012, Pages 2043-2051

  Hao, Zhi Ming ^a   Cai, Min ^a   Lv, Yi Fei ^a   Huang, Yan Hua ^a   Li, Hong Hong ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CARBON TETRACHLORIDE; CYCLINE; DESMIN; OSTEOGENIC PROTEIN 1; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GASTROINTESTINAL MUCOSA; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER FIBROSIS; LIVER PARENCHYMA; LIVER REGENERATION; MALE; MESENCHYME CELL; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; STELLATE CELL; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

ADENO-ASSOCIATED VIRUS; MUS;

EID: 84869090986     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.148     Document Type: Article

References (46)

1. Bataller, R and Brenner, DA (2005). Liver fibrosis. J Clin Invest 115: 209-218. (Pubitemid 40385459)
2. Thompson, AJ and Patel, K (2010). Antifibrotic therapies: Will we ever get there? Curr Gastroenterol Rep 12: 23-29.
3. Geerts, A, Lazou, JM, De Bleser, P and Wisse, E (1991). Tissue distribution, quantitation and proliferation kinetics of fat-storing cells in carbon tetrachloride-injured rat liver. Hepatology 13: 1193-1202.
4. Friedman, SL (1993). Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 328: 1828-1835. (Pubitemid 23174715)
5. Friedman, SL (2000). Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275: 2247-2250. (Pubitemid 30081976)
6. George, J, Roulot, D, Koteliansky, VE and Bissell, DM (1999). In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: A potential new therapy for hepatic fibrosis. Proc Natl Acad Sci USA 96: 12719-12724. (Pubitemid 29513569)
7. Shen, H, Huang, G, Hadi, M, Choy, P, Zhang, M, Minuk, GY et al. (2003). Transforming growth factor-beta1 downregulation of Smad1 gene expression in rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 285: G539-G546. (Pubitemid 37021813)
8. Liu, X, Hu, H and Yin, JQ (2006). Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis. Liver Int 26: 8-22.
9. Kingsley, DM (1994). The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8: 133-146.
10. Zaret, KS (2002). Regulatory phases of early liver development: Paradigms of organogenesis. Nat Rev Genet 3: 499-512. (Pubitemid 34746875)
11. Wang, SN, Lapage, J and Hirschberg, R (2001). Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J Am Soc Nephrol 12: 2392-2399. (Pubitemid 33021116)
12. Morrissey, J, Hruska, K, Guo, G, Wang, S, Chen, Q and Klahr, S (2002). Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 13 Suppl 1: S14-S21. (Pubitemid 34008173)
13. Wang, S, Chen, Q, Simon, TC, Strebeck, F, Chaudhary, L, Morrissey, J et al. (2003). Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int 63: 2037-2049. (Pubitemid 36605815)
14. Zeisberg, M, Hanai, J, Sugimoto, H, Mammoto, T, Charytan, D, Strutz, F et al. (2003). BMP-7 counteracts TGF-beta1-induced epithelial-To-mesenchymal transition and reverses chronic renal injury. Nat Med 9: 964-968. (Pubitemid 36889942)
15. Zeisberg, M, Bottiglio, C, Kumar, N, Maeshima, Y, Strutz, F, Muller, GA et al. (2003). Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol 285: F1060-F1067. (Pubitemid 37421041)
16. Izumi, N, Mizuguchi, S, Inagaki, Y, Saika, S, Kawada, N, Nakajima, Y et al. (2006). BMP-7 opposes TGF-beta1-mediated collagen induction in mouse pulmonary myofibroblasts through Id2. Am J Physiol Lung Cell Mol Physiol 290: L120-L126.
17. Myllarniemi, M, Lindholm, P, Ryynanen, MJ, Kliment, CR, Salmenkivi, K, Keski-Oja, J et al. (2008). Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis. Am J Respir Crit Care Med 177: 321-329. (Pubitemid 351198376)
18. Kinoshita, K, Iimuro, Y, Otogawa, K, Saika, S, Inagaki, Y, Nakajima, Y et al. (2007). Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats. Gut 56: 706-714. (Pubitemid 46662939)
19. Zeisberg, M, Yang, C, Martino, M, Duncan, MB, Rieder, F, Tanjore, H et al. (2007). Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 282: 23337-23347. (Pubitemid 47311952)
20. Zeisberg, EM, Tarnavski, O, Zeisberg, M, Dorfman, AL, McMullen, JR, Gustafsson, E et al. (2007). Endothelial-To-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13: 952-961. (Pubitemid 47222040)
21. Loureiro, J, Schilte, M, Aguilera, A, Albar-Vizcaino, P, Ramirez-Huesca, M, Perez-Lozano, ML et al. (2010). BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure. Nephrol Dial Transplant 25: 1098-1108.
22. Phillips, AO and Fraser, DJ (2010). BMP-7 stops TGF-{beta} in peritoneal fibrosis. Nephrol Dial Transplant 25: 1036-1038.
23. Khan, I, Agarwal, P, Thangjam, GS, Radhesh, R, Rao, SG and Kondaiah, P (2011). Role of TGF-s and BMP7 in the pathogenesis of oral submucous fibrosis. Growth Factors 29: 119-127.
24. Maric, I, Poljak, L, Zoricic, S, Bobinac, D, Bosukonda, D, Sampath, KT et al. (2003). Bone morphogenetic protein-7 reduces the severity of colon tissue damage and accelerates the healing of inflammatory bowel disease in rats. J Cell Physiol 196: 258-264. (Pubitemid 36775872)
25. Ballardini, G, Fallani, M, Biagini, G, Bianchi, FB and Pisi, E (1988). Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis. Virchows Arch, B, Cell Pathol 56: 45-49. (Pubitemid 18263701)
26. Cassiman, D, Libbrecht, L, Desmet, V, Denef, C and Roskams, T (2002). Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 36: 200-209. (Pubitemid 34146426)
27. Tacke, F, Gabele, E, Bataille, F, Schwabe, RF, Hellerbrand, C, Klebl, F et al. (2007). Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells. Dig Dis Sci 52: 3404-3415. (Pubitemid 350077191)
28. Yata, Y, Gotwals, P, Koteliansky, V and Rockey, DC (2002). Dose-Dependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: Implications for antifibrotic therapy. Hepatology 35: 1022-1030. (Pubitemid 34453999)
29. Kowdley, K, McCaughan, G and Trautwein, C (2007). Liver fibrosis: The hepatocyte revisited. Hepatology 46: 1659-1661.
30. Vukicevic, S, Latin, V, Chen, P, Batorsky, R, Reddi, AH and Sampath, TK (1994). Localization of osteogenic protein-1 (bone morphogenetic protein-7) during human embryonic development: High affinity binding to basement membranes. Biochem Biophys Res Commun 198: 693-700. (Pubitemid 24178423)
31. Sugimoto, H, Yang, C, LeBleu, VS, Soubasakos, MA, Giraldo, M, Zeisberg, M et al. (2007). BMP-7 functions as a novel hormone to facilitate liver regeneration. FASEB J 21: 256-264. (Pubitemid 46052564)
32. Chayanupatkul, M, Honsawek, S, Vejchapipat, P, Chongsrisawat, V and Poovorawan, Y (2009). Elevated serum bone morphogenetic protein 7 levels and clinical outcome in children with biliary atresia. Eur J Pediatr Surg 19: 246-250.
33. Hogan, BL (1996). Bone morphogenetic proteins in development. Curr Opin Genet Dev 6: 432-438. (Pubitemid 26280795)
34. Van Der Laan, LJ, Wang, Y, Tilanus, HW, Janssen, HL and Pan, Q (2011). AAV-mediated gene therapy for liver diseases: The prime candidate for clinical application? Expert Opin Biol Ther 11: 315-327.
35. During, MJ, Xu, R, Young, D, Kaplitt, MG, Sherwin, RS and Leone, P (1998). Peroral gene therapy of lactose intolerance using an adeno-Associated virus vector. Nat Med 4: 1131-1135. (Pubitemid 28468825)
36. Shao, G, Greathouse, K, Huang, Q, Wang, CM and Sferra, TJ (2006). Gene transfer to the gastrointestinal tract after peroral administration of recombinant adeno-Associated virus type 2 vectors. J Pediatr Gastroenterol Nutr 43: 168-179. (Pubitemid 44180500)
37. Polyak, S, Mah, C, Porvasnik, S, Herlihy, JD, Campbell-Thompson, M, Byrne, BJ et al. (2008). Gene delivery to intestinal epithelial cells in vitro and in vivo with recombinant adeno-Associated virus types 1, 2 and 5. Dig Dis Sci 53: 1261-1270. (Pubitemid 351514644)
38. During, MJ, Symes, CW, Lawlor, PA, Lin, J, Dunning, J, Fitzsimons, HL et al. (2000). An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science 287: 1453-1460. (Pubitemid 30127132)
39. Dumon, KR, Ishii, H, Fong, LY, Zanesi, N, Fidanza, V, Mancini, R et al. (2001). FHIT gene therapy prevents tumor development in Fhit-Deficient mice. Proc Natl Acad Sci USA 98: 3346-3351. (Pubitemid 32220848)
40. Xin, KQ, Ooki, T, Mizukami, H, Hamajima, K, Okudela, K, Hashimoto, K et al. (2002). Oral administration of recombinant adeno-Associated virus elicits human immunodeficiency virus-specific immune responses. Hum Gene Ther 13: 1571-1581. (Pubitemid 35034677)
41. Hara, H, Monsonego, A, Yuasa, K, Adachi, K, Xiao, X, Takeda, S et al. (2004). Development of a safe oral Abeta vaccine using recombinant adeno-Associated virus vector for Alzheimer's disease. J Alzheimers Dis 6: 483-488. (Pubitemid 40916690)
42. Ma, H, Liu, Y, Liu, S, Xu, R and Zheng, D (2005). Oral adeno-Associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice. Hepatology 42: 1355-1363. (Pubitemid 43260038)
43. Mouri, A, Noda, Y, Hara, H, Mizoguchi, H, Tabira, T and Nabeshima, T (2007). Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model. FASEB J 21: 2135-2148. (Pubitemid 47026449)
44. Berns, KI and Hauswirth, WW (1979). Adeno-Associated viruses. Adv Virus Res 25: 407-449. (Pubitemid 10097827)
45. Ishak, K, Baptista, A, Bianchi, L, Callea, F, De Groote, J, Gudat, F et al. (1995). Histological grading and staging of chronic hepatitis. J Hepatol 22: 696-699.
46. Reddy, GK and Enwemeka, CS (1996). A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 29: 225-229. (Pubitemid 26142071)